Chargement en cours...
Anticancer activity of NOB1-targeted shRNA combination with TRAIL in epithelial ovarian cancer cells
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) based strategy is a promising targeted therapeutic approach for the treatment of ovarian cancer. However, the effectiveness of the treatment remains limited due to the inherent or acquired resistance of tumor cells to TRAIL. Our previou...
Enregistré dans:
| Publié dans: | Int J Clin Exp Pathol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
e-Century Publishing Corporation
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4637528/ https://ncbi.nlm.nih.gov/pubmed/26617713 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|